CGA-IGC Podcast Series CGA-IGC
-
- Education
The Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC) was established in 1995 to improve understanding of the basic science of inherited colorectal cancer and the clinical management of affected families, with an emphasis on the particular aspects of caring for families living in the Americas. The Expert Approach to Hereditary Gastrointestinal Cancers podcast series (seasons 1 and 2), and more recently, the Journal Club podcast series (season 3, 4, 5), are presented by the CGA-IGC Education Committee.
-
Season 7 - Episode 2: Decisional regret post-prophylactic gastrectomy for Hereditary Diffuse Gastric Cancer (HDGC)
This episode is hosted by Josie Baker, MS, LGC, and features Jeremy Davis, MD, a National Cancer Institute (NIH) surgical oncologist.Together, they discuss Dr. Davis’ recent article published in the Journal of Medical Genetics titled “Decision-making and regret in patients with germline CDH1 variants undergoing prophylactic total gastrectomy.”This podcast was released during Patient Experience Week. Read our blog post to learn more about this podcast HERE
-
Season 7 - Episode 1: Constitutional MLH1 hypermethylation
This episode is hosted by Emma Keel, MS, CGC, and features Megan Hoenig, MS, MPH, CGC a certified genetic counselor at the Mayo Clinic. Together, they discuss the contribution of MLH1 constitutional methylation to Lynch syndrome diagnosis. They also explore disease definitions and mechanisms and current genetic testing guidelines while discussing the open questions in the field. This podcast was released on #LynchSyndromeAwarenessDay. Read our blog post "MLH1 hypermethylation during #LynchSyndromeAwarenessDay" here https://tinyurl.com/3zkurynf
-
Episode 5: S.6 Ep.5 Position statement of the International Society for Gastrointestinal Hereditary Tumours (InSiGHT) on APC I1307K and Cancer Risk
This episode is hosted by Thomas Slavin, MD, FACMG, DABMD, a Chief Scientific Officer at HALO Precision Diagnostics and features Laura Valle, PhD, a Principal Investigator, at the Catalan Institute of Oncology, IDIBELL. They discuss the position statement on the APC I1307K allele and its association with cancer predisposition which was generated by a multidisciplinary international expert group endorsed by the International Society for Gastrointestinal Hereditary Tumours (InSiGHT). Read our blog post "Evidence based guidance for APC I1307K and Cancer Risk" hereStay tuned for more podcasts in 2024! If you missed any of our earlier 2023 podcasts, you can find them here
-
Episode 4: S.6 Ep.4 Fight CRC Advocate Danielle Ripley-Burgess: "Life After Total Proctocolectomy in Lynch Syndrome”
This episode is hosted by Thomas Slavin, MD, FACMG, DABMD, a Chief Scientific Officer, and Emma Keel, MS, CGC, a genetic counselor, who have the privilege of speaking with Danielle Ripley-Burgess as she shares her story and experience on "Life After Total Proctocolectomy in Lynch Syndrome.”We're incredibly grateful that she took the time to share her story with us, and we hope it will give our members and the broader #HereditaryGICancer community greater insight into the patient's perspective.
-
Episode 3: S.6 Ep.3 Clinical characteristics of pancreatic and biliary tract cancers in Lynch syndrome: A retrospective analysis from the Finnish National Lynch Syndrome Research Registry
This episode is hosted by Julie Yang, MD, a gastroenterologist at the Icann School of Medicine at Mount Sinai, New York, USA and features Toni T. Seppälä, M.D., PhD, a GI surgeon and Professor of Cancer Research at Tampere University, Helsinki, Finland. They discuss the results from a retrospective analysis published this year, “Clinical characteristics of pancreatic and biliary tract cancers in Lynch syndrome: A retrospective analysis from the Finnish National Lynch Syndrome Research Registry," which can be found here. Read our blog post "Insights gained from the largest cohort of patients with pancreaticobiliary cancer and Lynch Syndrome" here
-
Episode 2: S.6 Ep.2 Considerations for individuals with Hereditary Diffuse Gastric Cancer Syndrome when considering a prophylactic gastrectomy
This episode is hosted by Josie Baker, MS, CGC, a genetic counselor at The Ohio State University, and features Rachael Lopez, MPH, RD, CSO, a clinical research dietitian at the National Institutes of Health. Together they discuss the considerations for individuals with Hereditary Diffuse Gastric Cancer Syndrome when considering a prophylactic gastrectomy. This episode highlights the professional experience when working with these individuals before and after surgery, as well as the challenges individuals may face during this process.